Consumer Health in Greece

Consumer Health in Greece

EXECUTIVE SUMMARY

Consumer health reshaped by legislative changes

Sales increase amid price hikes and an increase in self-medication

Depon remains the undisputed leading brand

Despite the liberation of OTC products’ distribution, chemists/pharmacies continues to hold the lion’s share

Forecasts are optimistic for consumer health

MARKET INDICATORS

Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 2 Life Expectancy at Birth 2013-2018

MARKET DATA

Table 3 Sales of Consumer Health by Category: Value 2013-2018
Table 4 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 5 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 6 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 7 Distribution of Consumer Health by Format: % Value 2013-2018
Table 8 Distribution of Consumer Health by Format and Category: % Value 2018
Table 9 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

SOURCES

Summary 1 Research Sources

Analgesics in Greece

HEADLINES

PROSPECTS

Growth hindered by the prevalence of non-OTC brands

Specialised products could give a boost in value

Demand for quick relief drives growth for max strength products

COMPETITIVE LANDSCAPE

Depon leads analgesics sales

GSK Consumer Healthcare gains share, driven by Panadol’s good performance

Bayer expands its Aspirin portfolio

CATEGORY DATA

Table 11 Sales of Analgesics by Category: Value 2013-2018
Table 12 Sales of Analgesics by Category: % Value Growth 2013-2018
Table 13 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2013-2018
Table 14 NBO Company Shares of Analgesics: % Value 2014-2018
Table 15 LBN Brand Shares of Analgesics: % Value 2015-2018
Table 16 Forecast Sales of Analgesics by Category: Value 2018-2023
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2018-2023

Cough, Cold and Allergy (Hay Fever) Remedies in Greece

HEADLINES

PROSPECTS

Self-medication prevails for treating colds, flu and mild allergies

Dust in the atmosphere results in new allergies and breathing conditions

Switches and launches result in an increase in product variety

COMPETITIVE LANDSCAPE

GSK Consumer Healthcare leads sales

Sanofi-Aventis ranks third in cough, cold and allergy (hay fever) remedies

Zirtek sales post a strong increase in 2018

CATEGORY DATA

Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2013-2018
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2013-2018
Table 20 Sales of Decongestants by Category: Value 2013-2018
Table 21 Sales of Decongestants by Category: % Value Growth 2013-2018
Table 22 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2018
Table 23 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2018
Table 24 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023
Table 25 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023

Dermatologicals in Greece

HEADLINES

PROSPECTS

Limited product variety hinders growth potential

External factors affect growth opportunities

Price increases translate into growth

COMPETITIVE LANDSCAPE

Johnson & Johnson leads sales

GSK Consumer Healthcare ranks second

Betadine maintains its sales thanks to a loyal consumer base

CATEGORY DATA

Table 26 Sales of Dermatologicals by Category: Value 2013-2018
Table 27 Sales of Dermatologicals by Category: % Value Growth 2013-2018
Table 28 NBO Company Shares of Dermatologicals: % Value 2014-2018
Table 29 LBN Brand Shares of Dermatologicals: % Value 2015-2018
Table 30 LBN Brand Shares of Hair Loss Treatments: % Value 2015-2018
Table 31 Forecast Sales of Dermatologicals by Category: Value 2018-2023
Table 32 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023

Dietary Supplements in Greece

HEADLINES

PROSPECTS

Consumption of supplements is on the rise driven by an increase in consumer awareness

The decline of retail prices contributes to growth

Several categories of dietary supplements lose momentum

COMPETITIVE LANDSCAPE

GR Sarantis continues to lose share

Dietary supplements is becoming more fragmented

Advertising is key to boosting sales

CATEGORY DATA

Table 33 Sales of Dietary Supplements by Category: Value 2013-2018
Table 34 Sales of Dietary Supplements by Category: % Value Growth 2013-2018
Table 35 Sales of Dietary Supplements by Positioning: % Value 2013-2018
Table 36 Sales of Fish Oils/Omega Fatty Acids by Type: % Value 2013-2018
Table 37 NBO Company Shares of Dietary Supplements: % Value 2014-2018
Table 38 LBN Brand Shares of Dietary Supplements: % Value 2015-2018
Table 39 Forecast Sales of Dietary Supplements by Category: Value 2018-2023
Table 40 Forecast Sales of Dietary Supplements by Category: % Value Growth 2018-2023

Digestive Remedies in Greece

HEADLINES

PROSPECTS

Changes in nutritional habits and the use of supplements affect performance

Natural solutions are increasingly preferred

Price liberation translates into growth

COMPETITIVE LANDSCAPE

Sanofi-Aventis is the leading company in digestive remedies

GSK Consumer Healthcare’s Zantac is the best-selling brand in value terms

Johnson & Johnson loses share yet retains its dominance of diarrhoeal remedies

CATEGORY DATA

Table 41 Sales of Digestive Remedies by Category: Value 2013-2018
Table 42 Sales of Digestive Remedies by Category: % Value Growth 2013-2018
Table 43 NBO Company Shares of Digestive Remedies: % Value 2014-2018
Table 44 LBN Brand Shares of Digestive Remedies: % Value 2015-2018
Table 45 Forecast Sales of Digestive Remedies by Category: Value 2018-2023
Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2018-2023

Eye Care in Greece

HEADLINES

PROSPECTS

Allergy eye care benefits from weather conditions

African dust benefits sales of standard eye care

Chemists/pharmacies is the dominant channel

COMPETITIVE LANDSCAPE

Alcon Laboratories Hellas Commercial & Industrial leads sales

Johnson & Johnson Hellas SA leads allergy eye care

CATEGORY DATA

Table 47 Sales of Eye Care by Category: Value 2013-2018
Table 48 Sales of Eye Care by Category: % Value Growth 2013-2018
Table 49 Sales of Standard Eye Care by Format: % Value 2013-2018
Table 50 Sales of Standard Eye Care by Positioning: % Value 2013-2018
Table 51 NBO Company Shares of Eye Care: % Value 2014-2018
Table 52 LBN Brand Shares of Eye Care: % Value 2015-2018
Table 53 Forecast Sales of Eye Care by Category: Value 2018-2023
Table 54 Forecast Sales of Eye Care by Category: % Value Growth 2018-2023

Herbal/Traditional Products in Greece

HEADLINES

PROSPECTS

Herbal/traditional products still represent growth opportunities

Driven by the rise in demand product variety is increasing

Maturity affects growth potential for herbal/traditional cough, cold and allergy (hay fever) remedies

COMPETITIVE LANDSCAPE

Mondelez Hellas SA leads sales

Power Health Hellas ranks second

Herbal/traditional products becomes more fragmented

CATEGORY DATA

Table 55 Sales of Herbal/Traditional Products by Category: Value 2013-2018
Table 56 Sales of Herbal/Traditional Products by Category: % Value Growth 2013-2018
Table 57 NBO Company Shares of Herbal/Traditional Products: % Value 2014-2018
Table 58 LBN Brand Shares of Herbal/Traditional Products: % Value 2015-2018
Table 59 Forecast Sales of Herbal/Traditional Products by Category: Value 2018-2023
Table 60 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2018-2023

NRT Smoking Cessation Aids in Greece

HEADLINES

PROSPECTS

Growth of NRT smoking cessation aids is hindered by maturity and the rise of alternatives

NRT gum dominates sales

COMPETITIVE LANDSCAPE

Johnson & Johnson dominates sales

NRT smoking cessation aids remains very consolidated

CATEGORY INDICATORS

Table 61 Number of Smokers by Gender 2013-2018

CATEGORY DATA

Table 62 Sales of NRT Smoking Cessation Aids by Category: Value 2013-2018
Table 63 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2013-2018
Table 64 Sales of NRT Gum by Flavour: % Value 2013-2018
Table 65 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2014-2018
Table 66 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2015-2018
Table 67 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2018-2023
Table 68 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2018-2023

Paediatric Consumer Health in Greece

HEADLINES

PROSPECTS

Parents are reluctant to use self-medication

Syrups remain the most popular delivery format

Paediatric ibuprofen will drive sales growth

COMPETITIVE LANDSCAPE

Vian SA leads sales

Uni-Pharma ranks second

CATEGORY DATA

Table 69 Sales of Paediatric Consumer Health by Category: Value 2013-2018
Table 70 Sales of Paediatric Consumer Health by Category: % Value Growth 2013-2018
Table 71 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2018
Table 72 NBO Company Shares of Paediatric Consumer Health: % Value 2014-2018
Table 73 LBN Brand Shares of Paediatric Consumer Health: % Value 2015-2018
Table 74 Forecast Sales of Paediatric Consumer Health by Category: Value 2018-2023
Table 75 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2018-2023

Sleep Aids in Greece

HEADLINES

PROSPECTS

High levels of anxiety result in an expansion of the consumer base for sleep aids

Herbal products attract new consumers to sleep aids

Greater penetration and maturity means slowing growth rates ahead

COMPETITIVE LANDSCAPE

Lanes Quiet Life leads sales

Fragmentation leads to losses for most key brands

Valerian remains the most popular ingredient

CATEGORY DATA

Table 76 Sales of Sleep Aids: Value 2013-2018
Table 77 Sales of Sleep Aids: % Value Growth 2013-2018
Table 78 NBO Company Shares of Sleep Aids: % Value 2014-2018
Table 79 LBN Brand Shares of Sleep Aids: % Value 2015-2018
Table 80 Forecast Sales of Sleep Aids: Value 2018-2023
Table 81 Forecast Sales of Sleep Aids: % Value Growth 2018-2023

Sports Nutrition in Greece

HEADLINES

PROSPECTS

Increase in gym memberships creates growth opportunities

Product variety grows amid the proliferation of internet retailing

Sports protein powder leads sales of sports nutrition

COMPETITIVE LANDSCAPE

X-Treme Stores leads sales

Sports nutrition is very fragmented

International brands hold the lion’s share

CATEGORY DATA

Table 82 Sales of Sports Nutrition by Category: Value 2013-2018
Table 83 Sales of Sports Nutrition by Category: % Value Growth 2013-2018
Table 84 NBO Company Shares of Sports Nutrition: % Value 2014-2018
Table 85 LBN Brand Shares of Sports Nutrition: % Value 2015-2018
Table 86 Forecast Sales of Sports Nutrition by Category: Value 2018-2023
Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2018-2023

Vitamins in Greece

HEADLINES

PROSPECTS

Vitamins sales continue to increase despite being affected by maturity

Multivitamins continues to attract investment

Retail prices decline due to discounts and competition

COMPETITIVE LANDSCAPE

GR Sarantis leads sales

Vianex’s new brand Eviol is prominent

Fragmentation and maturity lead to losses for Pfizer

CATEGORY DATA

Table 88 Sales of Vitamins by Category: Value 2013-2018
Table 89 Sales of Vitamins by Category: % Value Growth 2013-2018
Table 90 Sales of Multivitamins by Positioning: % Value 2013-2018
Table 91 NBO Company Shares of Vitamins: % Value 2014-2018
Table 92 LBN Brand Shares of Vitamins: % Value 2015-2018
Table 93 Forecast Sales of Vitamins by Category: Value 2018-2023
Table 94 Forecast Sales of Vitamins by Category: % Value Growth 2018-2023

Weight Management and Wellbeing in Greece

HEADLINES

PROSPECTS

Balanced nutrition favoured over the use of weight management products

Supplement nutrition drinks performs best

Sales remain seasonal

COMPETITIVE LANDSCAPE

Power Health Hellas leads sales

Price shapes value shares

Solgar Lipotropic Factors benefits from strong advertising support

CATEGORY DATA

Table 95 Sales of Weight Management and Wellbeing by Category: Value 2013-2018
Table 96 Sales of Weight Management and Wellbeing by Category: % Value Growth 2013-2018
Table 97 NBO Company Shares of Weight Management and Wellbeing: % Value 2014-2018
Table 98 LBN Brand Shares of Weight Management and Wellbeing: % Value 2015-2018
Table 99 Forecast Sales of Weight Management and Wellbeing by Category: Value 2018-2023
Table 100 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2018-2023

Wound Care in Greece

HEADLINES

PROSPECTS

Value growth is hindered by consumers trading down

Decline rate slows down

Maturity and a lack of investment or innovation are obstacles to growth

COMPETITIVE LANDSCAPE

Beiersdorf leads sales

Private label products gain share

CATEGORY DATA

Table 101 Sales of Wound Care by Category: Value 2013-2018
Table 102 Sales of Wound Care by Category: % Value Growth 2013-2018
Table 103 NBO Company Shares of Wound Care: % Value 2014-2018
Table 104 LBN Brand Shares of Wound Care: % Value 2015-2018
Table 105 Forecast Sales of Wound Care by Category: Value 2018-2023
Table 106 Forecast Sales of Wound Care by Category: % Value Growth 2018-2023

---